HalophFGD

Chromosome	Start	End	Strand	ID
BH04	28813642	28828020	+	BH04.1700

Theoretical pI	Molecular Weight	Instability Index	Aliphatic Index	GRAVY
8.76	249,042.48 Da	41.53	79.80	-0.38

Category	ID	Description	Start	End	Evalue/Score	InterPro ID
CDD	cd00303	retropepsin_like	458	552	2.75795E-11	-
CDD	cd01647	RT_LTR	770	950	2.00561E-78	-
CDD	cd09279	RNase_HI_like	1013	1090	5.80312E-27	-
Pfam	PF14392	Zinc knuckle	1988	2033	6.7E-9	IPR025836
Pfam	PF14111	Domain of unknown function (DUF4283)	1849	1985	4.7E-19	IPR025558
Pfam	PF00078	Reverse transcriptase (RNA-dependent DNA polymerase)	788	950	6.0E-21	IPR000477
Pfam	PF00067	Cytochrome P450	1386	1818	4.1E-50	IPR001128
Pfam	PF17921	Integrase zinc binding domain	1095	1143	2.3E-7	IPR041588
Pfam	PF13456	Reverse transcriptase-like	1017	1093	2.0E-11	IPR002156
SUPERFAMILY	SSF56672	DNA/RNA polymerases	730	1091	3.22E-85	IPR043502
SUPERFAMILY	SSF50630	Acid proteases	456	557	8.06E-8	IPR021109
SUPERFAMILY	SSF53098	Ribonuclease H-like	1158	1264	3.22E-17	IPR012337
SUPERFAMILY	SSF48264	Cytochrome P450	1380	1807	1.44E-78	IPR036396
Gene3D	G3DSA:2.40.70.10	Acid Proteases	442	569	2.4E-15	IPR021109
Gene3D	G3DSA:3.30.420.10	-	1152	1207	5.4E-9	IPR036397
Gene3D	G3DSA:1.10.630.10	Cytochrome P450	1374	1834	1.3E-95	IPR036396
Gene3D	G3DSA:3.30.420.10	-	1208	1299	3.0E-14	IPR036397
Gene3D	G3DSA:3.10.10.10	HIV Type 1 Reverse Transcriptase, subunit A, domain 1	731	875	6.7E-60	-
Gene3D	G3DSA:3.30.420.10	-	1014	1120	4.8E-17	IPR036397
Gene3D	G3DSA:3.30.70.270	-	813	950	6.7E-60	IPR043128
ProSiteProfiles	PS50878	Reverse transcriptase (RT) catalytic domain profile.	768	950	9.142104	IPR000477
ProSiteProfiles	PS50879	RNase H domain profile.	1009	1149	9.111221	IPR002156
ProSitePatterns	PS00086	Cytochrome P450 cysteine heme-iron ligand signature.	1770	1779	-	IPR017972
PRINTS	PR00465	E-class P450 group IV signature	1761	1777	2.9E-20	IPR002403
PRINTS	PR00465	E-class P450 group IV signature	1777	1795	2.9E-20	IPR002403
PRINTS	PR00465	E-class P450 group IV signature	1735	1753	2.9E-20	IPR002403
PRINTS	PR00465	E-class P450 group IV signature	1405	1428	2.9E-20	IPR002403
PRINTS	PR00465	E-class P450 group IV signature	1681	1697	2.9E-20	IPR002403
PRINTS	PR00465	E-class P450 group IV signature	1623	1649	2.9E-20	IPR002403
MobiDBLite	mobidb-lite	consensus disorder prediction	2101	2125	-	-
MobiDBLite	mobidb-lite	consensus disorder prediction	2184	2220	-	-
MobiDBLite	mobidb-lite	consensus disorder prediction	215	234	-	-
MobiDBLite	mobidb-lite	consensus disorder prediction	365	395	-	-
MobiDBLite	mobidb-lite	consensus disorder prediction	2060	2220	-	-
MobiDBLite	mobidb-lite	consensus disorder prediction	587	633	-	-
MobiDBLite	mobidb-lite	consensus disorder prediction	2140	2154	-	-

GO:0003676 (nucleic acid binding) GO:0004497 (monooxygenase activity) GO:0004523 (RNA-DNA hybrid ribonuclease activity) GO:0005506 (iron ion binding) GO:0016705 (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen) GO:0020037 (heme binding)

K05917 (sterol 14alpha-demethylase [EC:1.14.14.154 1.14.15.36])

ko00100 (Steroid biosynthesis) map00100 (Steroid biosynthesis) ko01100 (Metabolic pathways) map01100 (Metabolic pathways) ko01110 (Biosynthesis of secondary metabolites) map01110 (Biosynthesis of secondary metabolites)

R05640 (Lanosterol + 3 [Reduced NADPH---hemoprotein reductase] + 3 Oxygen <=> 4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + Formate + 3 [Oxidized NADPH---hemoprotein reductase] + 4 H2O) R05731 (Obtusifoliol + 3 [Reduced NADPH---hemoprotein reductase] + 3 Oxygen <=> 4alpha-Methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol + Formate + 3 [Oxidized NADPH---hemoprotein reductase] + 4 H2O)